KRChoksey Research has reaffirmed its "BUY" call on Granules India Ltd, targeting a price of Rs 700, which presents an upside potential of 22.4% from its current market price (CMP) of Rs 572.

KRChoksey has recommended an "ACCUMULATE" rating for Cipla Ltd. with a target price of Rs 1,680, indicating a potential upside of 6.0% from the current market price of Rs 1,585.

KRChoksey has reaffirmed a ‘Buy’ recommendation for Supriya Lifescience Ltd.

Prabhudas Lilladher has issued an “Accumulate” rating on Cipla’s stock, suggesting a target price (TP) of Rs1,615 per share, with the current market price (CMP) standing at Rs1,478.

Prabhudas Lilladher reaffirms its "Buy" stance on Sun Pharmaceutical Industries Ltd. (SUNP), revising the target price to Rs.2,100 from Rs.1,885.

Prabhudas Lilladher has issued a BUY recommendation for Eris Lifesciences, setting a target price of Rs 1,420.